About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Side effect(s) of Golimumab

Read the side effects of Golimumab as described in the medical literature. In case of any doubt consult your doctor or pharmacist.

Most Serious- Severe infection and tumor.

Respiratory- Upper respiratory tract infection/inflammation.

Liver- Increased liver enzymes level.

Local- Redness.

Heart- High blood pressure.

Central Nervous System- Dizziness and tingling.

Miscellaneous- Sarcoidosis.

Other Precautions : * Avoid vaccination while taking this medication.
* Monitor liver function, complete blood count regularly while taking this medication.

Drug Name : Golimumab

Golimumab(Simponi) generic is a tumor necrosis factor (TNF) blocker, prescribed for rheumatoid arthritis, ankylosing spondylitis, moderate to severe ulcerative colitis either alone or with other medications. It blocks a protein named as TNF-alpha in the body.
More Info about Golimumab

Advertisement



Advertisement
Recommended Reading
Drugs A - Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Drugs Search


    Advertisement
    What's New on Medindia
    Vaccination  And Counter  Measures Against  Monkeypox
    Indian Railways Special Concession on Health Grounds
    COVID Toes
    View all

    Medindia Newsletters Subscribe to our Free Newsletters!
    Terms & Conditions and Privacy Policy.

    Most Popular on Medindia

    Daily Calorie Requirements How to Reduce School Bag Weight - Simple Tips Post-Nasal Drip Indian Medical Journals Drug - Food Interactions The Essence of Yoga Find a Doctor Hearing Loss Calculator Blood Donation - Recipients Color Blindness Calculator

    Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

    © All Rights Reserved 1997 - 2022

    This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use